Cargando…
Combined Effects of Exercise and Denosumab Treatment on Local Failure in Post-menopausal Osteoporosis–Insights from Bone Remodelling Simulations Accounting for Mineralisation and Damage
Denosumab has been shown to increase bone mineral density (BMD) and reduce the fracture risk in patients with post-menopausal osteoporosis (PMO). Increase in BMD is linked with an increase in bone matrix mineralisation due to suppression of bone remodelling. However, denosumab anti-resorptive action...
Autores principales: | Martínez-Reina, Javier, Calvo-Gallego, José L., Pivonka, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8212042/ https://www.ncbi.nlm.nih.gov/pubmed/34150724 http://dx.doi.org/10.3389/fbioe.2021.635056 |
Ejemplares similares
-
Assessment of Strategies for Safe Drug Discontinuation and Transition of Denosumab Treatment in PMO—Insights From a Mechanistic PK/PD Model of Bone Turnover
por: Martínez-Reina, Javier, et al.
Publicado: (2022) -
Spatio-temporal simulations of bone remodelling using a bone cell population model based on cell availability
por: Calvo-Gallego, José Luis, et al.
Publicado: (2023) -
Mechanistic PK-PD model of alendronate treatment of postmenopausal osteoporosis predicts bone site-specific response
por: Calvo-Gallego, José L., et al.
Publicado: (2022) -
Editorial: Bone integrity in patients with osteoporosis: Evaluation of fracture risk and influence of pharmacological treatments and mechanical aspects
por: Martínez-Reina, Javier, et al.
Publicado: (2023) -
Synthesis and characterization of novel denosumab/magnesium-based metal organic frameworks nanocomposite prepared by ultrasonic route as drug delivery system for the treatment of osteoporosis
por: Alsaikhan, Fahad, et al.
Publicado: (2023)